Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: an open-label, multiple-dose, controlled phase I study in adults.

Autor:	Schöller-Gyüre M (AUTHOR), Kakuda TN (AUTHOR), De Smedt G (AUTHOR), Woodfall B (AUTHOR), Berckmans C (AUTHOR), Peeters M (AUTHOR), Hoetelmans RMW (AUTHOR)
Zdroj:	Clinical Therapeutics. Feb2010, Vol. 32 Issue 2, p328-337. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect